GPC-3 Tumor Vaccine (Janda Biotechnology)

GPC-3肿瘤疫苗(简达生物医药)

Report date: 2026/04/23 20:00:25

Base Information

Drug NameGPC-3 Tumor Vaccine (Janda Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionAnti-Glypican-3Immunostimulants
TargetsGlypican-3
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJanda Biotechnology (Jiaxing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJanda Biotechnology (Jiaxing) Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A